Business

TOKYO/BENGALURU (Reuters) – Biogen and partner Eisai Co Ltd are ending two late-stage trials testing the experimental Alzheimer’s drug aducanumab, marking the latest setback for an industry racing to develop treatments for the memory-robbing disease. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder Analysts expect the
0 Comments
ADDIS ABABA/JAKARTA/WASHINGTON (Reuters) – Boeing Co faced growing pressure in Washington on Wednesday as U.S. lawmakers called for executives to testify about two crashed 737 MAX jets while the world’s biggest planemaker worked on returning the grounded fleet to the skies. Ethiopian Red Cross workers carry a body bag with the remains of Ethiopian Airlines
0 Comments
WASHINGTON (Reuters) – The Federal Reserve will remain the top holder of U.S. Treasuries for the foreseeable future after the central bank said it would stop shrinking its $4 trillion balance sheet by the end of September. FILE PHOTO: U.S. Federal Reserve Chairman Jerome Powell holds a news conference following the two-day Federal Open Market
0 Comments